Raymond Sanchez, M.D.
Chief Medical Officer
Raymond Sanchez, M.D., has served as our Chief Medical Officer since January 2019.
Prior to joining us, Dr. Sanchez held various roles of increasing responsibility at Otsuka Pharmaceutical Development and Commercialization, Inc., where he most recently served as senior vice president, global clinical development. Previously, Dr. Sanchez served as the chief medical officer of Avanir Pharmaceuticals Inc. and held leadership roles at Bristol-Myers Squibb and Purdue Pharma.
Dr. Sanchez is currently the executive co-chair of the International Society for CNS Drug Development (ISCDD), and a trustee and member of the board of directors of the Connecticut Mental Health Center Foundation, Yale School of Medicine, as well as several other not-for-profit organizations. In 2021, he was named as one of the ‘Top 100 Leaders in Healthcare’ by the International Forum on Advancements in Healthcare.
Dr. Sanchez received an A.B. from Northwestern University and an M.D. from the Feinberg School of Medicine at Northwestern University. He completed his residency training and fellowship in psychiatry at the Yale University Medical School, where he was appointed as an instructor.